Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Quay Pharma
Quay Pharma
Activities:
Packaging
Regulatory
Research & Development
Cleaning
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Drug Delivery
SGS Quay Pharma receives Queen’s Award for industry
Leading pharmaceutical contract development and manufacturing organisation (CDMO) SGS Quay Pharma has received its Queen’s Award for Enterprise
Finance
SGS makes full-service CDMO acquisition
The investment from SGS is hoped to enhance the development of the company’s work in live biotherapeutics, and its expansion in the United States
Drug Delivery
Quay Pharma partners with XenoGesis on drug development
The partnership aims to accelerate the drug development process for both companies’ clients
Analysis
Advanced equipment enables checking of herbal claims
Quay Pharma is using a Waters UPLC system to provide vital analysis for herbal supplements
Drug Delivery
Drug delivery solution for the treatment of gastrointestinal disorders
Quay Pharma has developed a specialised filling system to enable a new treatment for anorectal diseases to enter Phase III clinical trials
Regulatory
Quay establishes biotherapeutic GMP suites
The UK based pharmaceutical outsourcing specialist continues to invest in its work in live biotherapeutics at its facility in Deeside, Flintshire, UK
Research & Development
Quay Pharma to supply promising cancer drug for trial
Quay Pharma has reached an agreement with Redx Pharma to manufacture Redx’s breakthrough cancer treatment drug
Subscribe now